Table 2 Participants’ underlying disease
Primary diagnosis | l-Carnitine group (n=24) | Control group (n=27) | P-value1 |
|---|---|---|---|
Respiratory diseases | 12 (50) | 8 (29.6) | 0.13 |
Hypertension | 10 (41.7) | 13 (48.1) | 0.64 |
Cardiovascular diseases | 10 (41.7) | 17 (63) | 0.128 |
Central nervous system problems | 8 (33.3) | 9 (33.3) | >0.99 |
Diabetes | 7 (29.2) | 7 (25.9) | 0.79 |
Stroke | 5 (20.8) | 8 (29.6) | 0.47 |
Cancer | 4 (16.7) | 3 (11.1) | 0.56 |
Gastrointestinal disease | 3 (12.5) | 3 (11.1) | 0.87 |